IFNG and ovarian cancer: Another cytokine with beneficial immune stimulatory and anti-tumor effects in ovarian cancer patients is IFNγ [35–38], consistent with the observation that IFNγ can prevent the skewing of monocyte differentiation by ovarian cancer ascites from immunostimulatory IL-10lowIL-12high macrophages to TAM-like IL-10highIL-12low cells [34].